Loading ...

Noha Lim, PhD

Immune Tolerance Network

Associate Director

Assessment Group

nlim@immunetolerance.org

Work:

240-235-6151

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN021AI

-

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

ITN027AI

-

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

ITN028AI

-

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ITN032AD

-

Promoting Tolerance to Peanut in High-Risk Children

ITN033AI

-

High Dose Immunosuppression and Autologous Stem Cell Transplantation for Multiple Sclerosis

ITN043AD

-

Long-Term Effects of Sublingual Grass Therapy

ITN049AD

-

Persistence of Oral Tolerance to Peanut

ITN051AI

-

Defining Immune Tolerance in ANCA-associated Vasculitis

ITN052AD

-

Peanut Protein Quantification Study for LEAP

ITN053AD

-

Peanut protein quantification study for LEAP-ON

ITN055AI

-

Rituximab and Belimumab for Lupus Nephritis

ITN057AD

-

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

ITN059AI

-

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris

ITN062ST

-

Tolerance by engaging antigen during cellular homeostasis

ITN064AI

-

Imaging of Type 1 Diabetes Progression

ITN066AI

-

Type 1 Diabetes Extension Study

ITN070AD

-

ITN077AI

-

Best Available Therapy Vs. Autologous Hematopoietic Stem Cell Transplant For MS

ITN819AI

-

Type 1 Diabetes Immunotherapy Using Polyclonal Tregs

ITN825AI

-

Imatinib in New-onset T1D

ITN827AI

-

Tregs and IL-2 in Type 1 Diabetes

Bio:

Admin Links

Shortcuts

ITN Documents

Links